발효울금 추출물을 유효성분으로 포함하는 위장질환의 예방 또는 치료용 조성물
    34.
    发明公开
    발효울금 추출물을 유효성분으로 포함하는 위장질환의 예방 또는 치료용 조성물 无效
    用于预防和治疗包含提取的CURCUMA LONGA L.的胃肠疾病的组合物

    公开(公告)号:KR1020140116282A

    公开(公告)日:2014-10-02

    申请号:KR1020130030381

    申请日:2013-03-21

    Abstract: The present invention provides a pharmaceutical composition comprising a fermented Curcuma longa extract as an active ingredient for preventing or treating gastro-intestinal diseases. The composition of the present invention improves the gastric mucosa protection or alleviates the gastric mucosal damage, and suppresses the inflammatory response in the stomach, thereby has an excellent effect for preventing and treating the gastro-intestinal diseases. The present invention provides a composition and a functional health food comprising the fermented Curcuma longa extract as an active ingredient for preventing or treating the gastro-intestinal diseases.

    Abstract translation: 本发明提供一种药物组合物,其包含发酵姜黄提取物作为预防或治疗胃肠疾病的活性成分。 本发明的组合物改善了胃粘膜保护或缓解胃粘膜损伤,抑制了胃中的炎症反应,因此对预防和治疗胃肠疾病具有极好的效果。 本发明提供一种组合物和功能保健食品,其包含发酵姜黄提取物作为预防或治疗胃肠疾病的活性成分。

    알파 글루코시다제 활성 저해용 조성물
    36.
    发明公开
    알파 글루코시다제 활성 저해용 조성물 有权
    α-葡萄糖苷酶抑制活性的组合物

    公开(公告)号:KR1020120119555A

    公开(公告)日:2012-10-31

    申请号:KR1020110037558

    申请日:2011-04-22

    Inventor: 오세종 전우진

    CPC classification number: A61K35/74 A23L33/10 A61K9/0053

    Abstract: PURPOSE: A composition for alpha glucosidase activity inhibition is provided to fundamentally reduce the amount of low sugar group which is absorbed into human body. CONSTITUTION: A composition for alpha glucosidase activity inhibition contains Pediococcus sp. JNU 534 (the accession number KCCM-10869P) strain or culture material of the Pediococcus species JNU 534 (the accession number KCCM-10869P) strain. A health supplement contains the composition for the alpha glucosidase activity inhibition. The foods are manufactured into formulations of powder, granule, tablet, capsule or drink medicine A food addition contains the composition for the alpha glucosidase activity inhibition. A fermented milk product contains the composition for the alpha glucosidase activity inhibition. A composition for preventing and treating anti-hyperglycemic contains the composition for the alpha glucosidase activity inhibition as an active ingredient.

    Abstract translation: 目的:提供一种用于α葡糖苷酶活性抑制的组合物,从根本上减少吸收到人体内的低糖组的量。 构成:用于α葡糖苷酶活性抑制的组合物含有球状球菌 菌种JNU 534(登录号KCCM-10869P)菌株或培养物种JNU 534(登录号KCCM-10869P)菌株。 健康补充剂含有α葡糖苷酶活性抑制的组合物。 食品被制成粉末,颗粒,片剂,胶囊或饮料药物的制剂。食品添加剂含有用于α-葡糖苷酶活性抑制的组合物。 发酵乳产品含有用于α-葡糖苷酶活性抑制的组合物。 用于预防和治疗抗高血糖的组合物含有作为活性成分的作为α葡糖苷酶活性抑制的组合物。

    울금 물 추출물의 분획물을 함유하는 알코올성 간 손상 예방용 약학적 조성물
    40.
    发明公开
    울금 물 추출물의 분획물을 함유하는 알코올성 간 손상 예방용 약학적 조성물 无效
    包含来自CURCUMA LONGA L.的水提取物的部分的药物组合物,用于预防酒精性肝损伤

    公开(公告)号:KR1020130019725A

    公开(公告)日:2013-02-27

    申请号:KR1020110081853

    申请日:2011-08-17

    Abstract: PURPOSE: A pharmaceutical composition containing a fraction of a Curcuma Longa L. extract for preventing alcoholic liver damage is provided to suppress generation of alcoholic lipid peroxide and to enhance antioxidation. CONSTITUTION: A pharmaceutical composition for preventing alcoholic liver damage contains a fraction of a Curcuma Longa L. water extract as an active ingredient. The fraction is prepared by extracting Curcuma Longa L. with hot water and fractioning with chloroform. The liver damage is alcoholic fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. A health functional food for preventing alcoholic liver damage contains the fraction as an active ingredient.

    Abstract translation: 目的:提供一种含有姜黄姜黄提取物用于预防酒精性肝损伤的药物组合物,以抑制酒精性脂质过氧化物的产生并增强抗氧化作用。 构成:用于预防酒精性肝损伤的药物组合物含有一部分作为活性成分的姜黄龙提取物。 通过用热水提取姜黄和用氯仿分级制备级分。 肝损害是酒精性脂肪肝,酒精性肝炎或酒精性肝硬化。 用于预防酒精性肝损伤的健康功能食品包含该部分作为活性成分。

Patent Agency Ranking